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Rett syndrome (RTT) is a neurological disorder characterized by motor and 
cognitive impairment, autonomic dysfunction and a loss of purposeful hand skills. 
In the majority of cases, typical RTT is caused by de novo mutations in the X-
linked gene, MECP2. Alterations in the structure and function of neurons within 
the central nervous system of RTT patients and Mecp2-null mouse models are well 
established. In contrast, few studies have investigated the effects of MeCP2-
deficiency on peripheral nerves. In this study, we conducted detailed morphometric 
as well as functional analysis of the sciatic nerves of symptomatic adult female 
Mecp2
+/-
 mice. We observed a significant reduction in the mean diameter of 
myelinated nerve fibers in Mecp2
+/-
 mice. In myelinated fibers, mitochondrial 
densities per unit area of axoplasm were significantly altered in Mecp2
+/-
 mice. 
However, conduction properties of the sciatic nerve of Mecp2 knockout mice were 
not different from control. These subtle changes in myelinated peripheral nerve 
fibers in heterozygous Mecp2 knockout mice could potentially explain some RTT 
phenotypes. 
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Introduction  
Rett syndrome (RTT; MIM 312750) is a neurological disorder characterized by a 
suite of motor and intellectual impairments with overt onset several months 
postnatally (Neul et al., 2010). In the vast majority of cases, typical RTT is caused 
by de novo loss-of-function mutations in the MECP2 gene (reviewed in (Gadalla et 
al., 2011; Lyst and Bird, 2015; Leonard et al., 2017). Several mouse models of 
RTT have been generated (Chen et al., 2001; Guy et al., 2001; Shahbazian et al., 
2002) and have been shown to recapitulate many of the features of RTT. Human 
postmortem studies report a range of structural changes in the RTT brain including 
reduced brain size and weight, reduced dendritic branching complexity and 
changes in spine density and morphology (Armstrong et al., 1995; Bauman et al., 
1995). Similar observations have been reported in Mecp2-null mice (Chen et al., 
2001; Nguyen et al., 2012; Robinson et al., 2012). Several studies have reported 
axonal neuropathy, degenerative changes and reduced numbers of large myelinated 
fibers in peripheral nerves in RTT patients (Haas and Love, 1988; Wakai et al., 
1990), as well as mitochondrial structural abnormalities in both nerve (Wakai et 
al., 1990) and skeletal muscle (Ruch et al., 1989). However, no studies have yet 
investigated the structure and function of peripheral nerves in mouse models of 
RTT. These nerves can be rapidly fixed, thus preserving ultrastructural features, 
and changes can be quantified making them useful in the study of the human 
disease. In this report, we have assessed structural and functional properties of the 
sciatic nerve from symptomatic heterozygous Mecp2
+/-
 mice, an accurate genetic 
model of RTT, using light and electron microscopy and ex vivo electrophysiology. 
The results demonstrate subtle structural changes in myelinated fibers that could 
potentially contribute to peripheral neuropathies in Rett syndrome, as previously 
inferred from human studies (Wakai et al., 1990).    
Material and methods 
Animals 
Light and electron microscopy analysis 
 All experiments were carried out in accordance with the European Communities 
Council Directive (86/609/EEC) and within the terms of a project license under the 
UK Animals (Scientific Procedures) Act (1986). Mecp2-null (Mecp2
tm1.1Bird
) mice, 
originally provided as a kind gift from Professor Adrian Bird (University of 
Edinburgh), were maintained on a C57BL/6 background. Experimental cohorts of 
Mecp2
+/- 
mice were generated by crossing Mecp2
+/-
 females with wild-type 
Mecp2
+/y
 males. Animals were maintained on 12-hour light/dark cycles with free 
access to normal mouse food. Mice were genotyped and scored for Rett-like 
phenotypes using an observational scale for mobility, gait, hindlimb clasping, 
abnormal breathing, tremor and general condition, as described previously (Guy et 
al., 2007). Unlike the male knockout (Mecp2
-/y
) mice, which develop RTT-like 
phenotypes very early in life, female heterozygotes (Mecp2
+/-
) variably develop 
these phenotypes later in their life (Guy et al., 2007). Therefore, this scoring 
system was used primarily to ensure that Mecp2
+/-
 mouse cohort in this study had 
reached the symptomatic phase of the disorder. 
Mecp2
+/-
 and wild-type (WT) female mice (8-9 months) were humanely sacrificed 
by cervical dislocation and the left sciatic nerve was exposed through a lateral 
incision in the mid-thigh. The proximal one-third of the nerve segment was 
dissected and immediately fixed in 2% paraformaldehyde + 2.5% glutaraldehyde in 
0.1M phosphate buffer (pH 7.4) for 1hr at room temperature. The nerve segments 
were then cut transversely into small (~1mm) blocks and placed in the same fresh 
fixative for an additional 12 hrs at 4°C. The nerve samples were then washed with 
0.1 phosphate buffer (3x15mins) and post-fixed in 1% osmium tetroxide in 
phosphate buffered solution for 25 mins at room temperature. Subsequently, the 
samples were washed in de-ionized H2O (3x10 mins) and gradually dehydrated in 
the following concentrations of acetone; 70% for 20 mins, 90% for 20 mins and 
100% acetone for 45 mins (3 washes of 15 mins each). Following dehydration, 
samples were incubated overnight in 1:1 (v/v) Durcupan (Sigma, UK)/ acetone 
(100%) mixture and then in 3:1 (v/v) Durcupan / acetone (100%) mixture for 3 hrs. 
The vials containing the samples were kept open to the air for at least 30 mins to 
evaporate the acetone, and this was followed by an incubation in fresh pure 
Durcupan for 24 hrs. This last step was repeated twice. Finally, the samples were 
embedded in a flat mould filled with fresh pure Durcupan and cured at 68°C for 48 
hrs. 
Transverse semi-thin (0.5 μm) sections of sciatic nerve were cut using a glass 
knife. The sections were deposited in a drop of distilled H2O onto agar coated glass 
slides and dried on a hot plate at 90°C. The slides were subsequently cooled to 
room temperature before staining sections with Azure blue (1%) on a hot plate at 
90°C (until a green ring appeared around the staining drop). The slides were rinsed 
with distilled H2O to remove the excess stain and left to dry at room temperature. 
The sections were then dehydrated in an ascending range of ethanol solutions; 
70%, 90% and finally 100% (3 times, 5 mins each), then cleared in Histo-clear (2 x 
5 mins; Agar Scientific, UK) before being mounted using Histo-mount (Agar 
Scientific, UK) and visualized by light microscopy. Images were captured using an 
AxioCam MRc digital camera (Zeiss, Cambridge, UK) mounted on a light 
microscope (Zeiss Axioscop50, Cambridge, UK).   
For analysis of nerve fiber morphology, random non-overlapping areas of interest 
(AOI; n =10) were acquired for each mouse sample using a 100X oil objective. 
Digital images were used to assess fiber size, density and g-ratio (the ratio of the 
axon diameter to the fiber [axon plus myelin sheath] diameter), which provides a 
measure of myelin thickness relative to axonal diameter (Gillespie and Stein, 1983; 
Michailov et al., 2004). Measurements of fiber and axon diameter were conducted, 
blinded to genotype, by tracing the outer and inner perimeters of the myelin 
sheaths of all fibers within, and touching north and east borders of, each AOI using 
Image J software (Abramoff et al., 2004). The perimeter measurements were then 
converted into diameters (Edgar et al., 2009).  
Transverse ultra-thin (80 nm) sections of sciatic nerve were cut using an ultra-
microtome equipped with a diamond knife. The sections were collected on coated 
copper grids and stained with 2% aqueous uranyl acetate for 10 mins and 0.5% 
lead citrate for 5 mins. Random non-overlapping AOIs (10 per mouse sample) 
were collected at ~7400x magnification by transmission electron microscopy 
(Philips CM100). These images were used to trace axonal and mitochondrial cross-
sectional areas and to quantify the density of unmyelinated nerve fibers and 
mitochondrial per myelinated axon cross section in all fibers within, and touching 
north and east borders of each AOI. Mitochondrial density was calculated by 
dividing the number of mitochondria per axonal cross-section by the mean axonal 
cross-sectional area for that genotype. This estimation is based on the assumption 
that, as in the optic nerve, mitochondria in myelinated axons greater than ~0.7 m 
diameter occupy a constant proportion of axonal cytoplasmic volume, independent 
of axonal diameter (Perge et al., 2009). Analysis of mitochondrial integrity was 
performed according to (Deighton et al., 2014). Mitochondria were considered 
normal if cristae were clearly visible and covered >50% of the matrix, abnormal if 
cristae were absent and/or the mitochondria were swollen, and uncertain if 
  
 
Statistical and data analysis  
Tests for differences between treatment groups were carried out in GraphPad 
PRISM using a Student’s t-test, two-way ANOVA or Chi-square test, as 
mitochondria contained slightly fewer cristae than normal but appeared otherwise 
normal. A minimum of 505 mitochondria were assessed per genotype. 
Extracellular sciatic nerve recordings
Mice for electrophysiology were killed by cervical dislocation and the right sciatic 
nerve trunk was removed from WT and Mecp2
+/- 
mice, taking care not to stretch 
the nerve. Nerves were mounted across 3 chambers in a Perspex recording block 
and sealed at chamber intervals with vacuum grease for recording. Recordings 
were performed as described previously (Yao et al., 2014). Briefly, nerve samples 
were maintained in Ringer’s solution and recordings performed at room 
temperature. Nerves were stimulated at 1 Hz and supramaximal voltage (Grass S88 
stimulator; Grass Instruments) for 30 mins to measure conduction velocity (CV). 
Signals were amplified (CED1902; Cambridge Electronic Design), digitized 
(NIDAQ-MX analog-to-digital converter; National Instruments), and analyzed 
using WinWCP version 4.5.2. The distance between the stimulating and recording 
electrodes was divided by the time between the stimulation artifact and the peak of 
compound action potential to calculate conduction velocity. 
Paired-pulse recordings were performed on the same nerve sample to assess 
refractoriness. To determine refractoriness, the percentage amplitude of the second 
waveform, elicited at intervals ranging from 3 to 30 ms, compared with the first 
was calculated for every inter-stimulus interval. At termination of the experiment, 
nerve crush was performed to confirm that the recorded waveform originated from 
real activity.  
appropriate. p < 0.05 was used to define statistical significance. For 
electrophysiological data, a two-way ANOVA was used to compare CV between 
genotypes and to compare paired-pulse amplitudes with increasing inter-stimulus 
interval. For g-ratio plots, non-linear regression analysis and least squares fit was 
conducted using Graphpad PRISM. 
Results 
Reduced diameter of myelinated fibers in Mecp2
+/-
 mice 
In order to establish if the structural and functional properties of peripheral nerve 
fibers are altered in an RTT model, the sciatic nerve was isolated from 8 month old 
female Mecp2
+/-
 mice (mosaic for functional MeCP2 expression) (n = 9) and wild-
type littermates (n = 5). To ensure that the Mecp2
+/-
 mouse cohort was 
symptomatic, mice were scored, prior to collecting tissues, using our standard 
aggregate phenotype severity scoring system, which is based on the presence of 
several RTT-like aspects of the phenotype (Guy et al., 2007; Gadalla et al., 2013; 
Garg et al., 2013). Post hoc analysis confirmed that the Mecp2
+/-
 mice used showed 
a significantly higher severity score than the WT group (1.88 ± 0.38 in Mecp2
+/-
 
vs. 0.20 ± 0.20 in WT mice, mean ± SEM, p = 0.0098, unpaired t test). In order to 
exclude the possibility of mouse size as a confounding factor affecting 
morphological measures, bodyweight and tibial length were measured. However, 
there was no significant difference in bodyweight (23.88 ± 0.98 g in WT vs. 26.49 
± 1.09 g in Mecp2
+/-
, mean ± SEM, p = 0.14, unpaired t test) or tibial length (17.00 
± 0.24 mm in WT vs. 17.11 ± 0.20 mm in Mecp2
+/-
, mean ± SEM, p = 0.40, 
unpaired t test) between genotypes.  
To assess the diameter of sciatic nerve fibers (axon plus myelin sheath) and their 
axons, semi-thin sections were prepared from sciatic nerve and stained with Azur 
Density and diameter of unmyelinated axons in Mecp2
+/-
 mice are not altered 
blue (figure 1A). Myelinated fiber diameters in the Mecp2
+/-
 mice were 
significantly reduced compared to WT controls (7.04 ± 0.20 µm and 8.89 ± 0.20 
µm respectively, mean ± SEM, p < 0.001, unpaired t test; figure 1B&C). Similarly, 
diameters of axons of these myelinated fibers in Mecp2
+/-
 mice were significantly 
reduced compared to WT (4.75 ± 0.20 µm and 6.03 ± 0.10 µm respectively, mean 
± SEM, p < 0.001, unpaired t test; figure 1D&E). As predicted on the basis of 
reduced diameters, the density of myelinated fibers in the Mecp2
+/-
 mice was 
significantly higher than in the WT (3.02 x 10
4
 ± 0.16 vs. 2.58 x 10
4
 ± 0.16 per 
mm
2
, respectively, mean ± SEM, p = 0.034, unpaired t test, figure 1F). We also 
estimated myelin thickness through subtraction of axonal diameter from fiber 
(axon plus myelin) diameter (figure 2A). The myelin thickness was significantly 
reduced in Mecp2
+/-
 mice compared to WT (Mecp2
+/-
 = 1.14 ± 0.04 µm, WT = 1.43 
± 0.09 µm, mean ± SEM, p = 0.006, unpaired t test, figure 2A). However, as all 
axons within an AOI were measured, these values partially reflect the fact that 
more small diameter fibers, with comparatively thin myelin sheaths, were 
quantified in the mutant. Therefore we determined if myelin sheaths were 
appropriately thick in relation to the diameter of their axons (small axons have 
thinner sheaths than large axons) by plotting g-ratio (ratio of axon diameter to fiber 
diameter) against axonal diameter (figure 2B). This revealed Mecp2
+/-
 axons to 
have slightly thinner than normal myelin sheaths (higher g-ratio) across the entire 
range of axon diameters. Pearson r values for axonal diameter versus g-ratio for 
WT fibers was 0.619 and for Mecp2
+/-
 fibers was 0.605, indicating a strong 
correlation between axonal diameter and g-ratio for both genotypes (p < 0.0001 for 
both WT and Mecp2
+/-
). 
  
To examine unmyelinated axons in the sciatic nerve, transverse ultrathin sections 
of nerve from Mecp2
+/-
 and WT mice were imaged by transmission electron 
microscopy (figure 3A-C). There was no significant difference in the diameter of 
the unmyelinated axons between WT and Mecp2
+/-
 mice (0.73 ± 0.01 µm vs. 0.71 
± 0.02 µm, respectively, mean ± SEM, p = 0.62, unpaired t test). There was also no 
difference in the density of unmyelinated axons between genotypes (1.86 ± 0.28 x 
10
5
 axons/mm
2
 and 2.32 ± 0.44 x 10
5
 axons/mm
2
 for WT and Mecp2
+/-
, 
respectively, mean ± SEM, p = 0.4, unpaired t test). 
Mitochondrial densities per unit area of axoplasm are increased in Mecp2
+/-
 
mice. 
Mitochondrial dysfunction has been previously reported in muscle biopsies from 
RTT patients (Wakai et al., 1990) and in the central nervous system of Mecp2-null 
mice (Grosser et al., 2012; De Filippis et al., 2015). We therefore investigated 
whether mitochondrial density was altered in sciatic nerve myelinated axons in 
Mecp2
+/-
 mice (figure 4A). Electron microscopic analysis revealed that the number 
of mitochondria per myelinated axon cross section in the sciatic nerve sections of 
Mecp2
+/-
 mice was significantly reduced compared to WT samples (1.62 ± 0.10 
and 2.02 ± 0.12 mitochondria per axon cross section, respectively, mean ± SEM, p 
= 0.03, unpaired t test, figure 4B). In contrast, the density of mitochondria per mm
2
 
of axoplasm of myelinated axons was significantly higher in the Mecp2
+/-
 
compared to WT mice (95.43 ± 6.81 x 10
3
 and 70.96 ± 3.94 x 10
3
 mitochondria per 
mm
2
, respectively, mean ± SEM, p = 0.012, unpaired t test; figure 4C). Unlike the 
differences observed above, there was no difference in mitochondrial morphology 
between Mecp2
+/-
 and WT mice (normal morphology; 87.06 ± 2.31% and 89 ± 
0.95%, abnormal; 7.73 ± 1.50% and 8.71 ±1.07%, uncertain; 5.21 ± 1.41% and 
2.28 ±1.01%, respectively, mean ± SEM, p > 0.05, Chi-square test, figure 5A&B). 
Further, there was no difference in the mean diameter of axonal mitochondria 
between the genotypes (WT = 0.31± 0.02 µm vs. Mecp2
+/-
 = 0.34 ± 0.02 µm, mean 
± SEM, p = 0.19, unpaired t test; figure 5C). 
Conduction properties of the sciatic nerve of Mecp2
+/-
 mice are unaltered 
Discussion   
In this study, we utilized morphometric and electrophysiological techniques to 
assess potential abnormalities in peripheral nerve structure and function arising 
from MeCP2 deficiency. We focused our study on symptomatic Mecp2-
heterozygous female mice as these model the genetic and molecular changes in 
RTT patients most accurately. Our main findings are the observed differences in 
the sciatic nerve fiber diameter and density, as well as the altered mitochondrial 
density in the myelinated axons of Mecp2
+/-
 mice. However, other morphological 
features such as density and diameter of unmyelinated axons were unaltered and 
we did not detect any functional impairment in terms of nerve conduction in whole 
nerve recordings. The sciatic nerve contains motor, sensory and autonomic nerve 
fibers and it is possible that the average values we obtained reflect a preferential 
effect on one or more of these populations. However, it is not possible in 
micrographs of resin sections or in electron micrographs to distinguish, with 
To test sciatic nerve conduction properties, 10 mm segments were collected 
immediately after death and mounted for electrophysiological extracellular 
recording. There was no difference in conduction velocity between genotypes 
across a range of stimulus intensities (p > 0.05, two-way ANOVA, figure 6 A&B). 
Similarly, paired-pulse stimulation revealed no difference in the refractory period 
between genotypes when tested across a range of inter-stimulus intervals (p > 0.05, 
two-way ANOVA, figure 6C).   
This, the first report of peripheral nerve phenotypes in mice modelling RTT, is 
broadly consistent with early clinical data showing ultrastructural abnormalities in 
the sural nerve, including a reduction in numbers of large myelinated fibers and 
mitochondrial alterations in myelinated axons (Wakai et al., 1990). We did not 
observe evidence of axonal degeneration, as previously reported in a number of 
human subjects (Haas and Love, 1988). However, this might reflect the fact that 
lifespan and peripheral nerve lengths are considerably shorter in mice than in 
humans, as both increasing age and axonal length are factors influencing the 
likelihood of occurrence of axonal pathology (Coleman, 2005; Adalbert and 
Coleman, 2013).  
In the current study, we observed myelinated fibers of reduced diameter in 
Mecp2
+/-
 mouse sciatic nerves (Figs 1 b, d and f). This was due to reductions in 
both axonal diameter and myelin sheath thickness (as shown by increased g-ratio), 
In other respects, Schwann cells appeared normal in Mecp2
+/-
 mice including well 
compacted myelin, lack of redundant myelin or tomaculae, and healthy-appearing 
Schwann cell nuclei (data not shown). Nonetheless, we do not exclude the 
possibility of other changes that were not assessed in this study.  For example, Pi-
granules (metachromatic granules) and swollen mitochondria have been reported in 
certainty, the fiber subtypes. Therefore, it is possible that certain populations were 
more affected by MeCP2 deficiency than others. We cannot exclude the possibility 
that the absence of detectable differences in conduction velocity in ex vivo nerve 
segments is related to the subtlety of the ultrastructural changes in the fiber 
diameters and the relatively short length of the mouse nerve preparation used for 
the electrophysiological studies (10 mm). However, nerve conduction velocity 
studies in patients, even in advanced stages of RTT, suggest only slight signs of 
peripheral nerve damage/dysfunction (Glaze, 2005).   
m. In comparison, the 
mean diameter of optic nerve axonal mitochondria is ~0.22 
At least in optic nerve axons, total mitochondrial volume (Vm) scales roughly in 
proportion to axonal diameter squared (Perge et al., 2009), and for axons > 0.7 m 
the cytoplasm of Schwann cells in clinical biopsies from RTT patients (Wakai et 
al., 1990).  
Multiple factors play a role in Schwann cell differentiation and myelination 
(Sherman and Brophy, 2005), but one factor in particular, neuregulin-1 (NRG1) 
type III, fine-tunes myelin sheath thickness to axon caliber (Michailov et al., 2004; 
Taveggia et al., 2005). Therefore, it will be interesting to determine if the slightly 
decreased myelin thickness (increased g-ratios) in Mecp2
+/-
 sciatic nerves is 
mirrored by a reduction in Nrg1 expression in Mecp2
+/-
 mouse neurons or whether 
this myelin phenotype reflects a Schwann cell autonomous effect. It is possible that 
the reduced axonal diameter in the RTT mouse model reflects a reduced 
arborisation of axon terminals per fiber (Perge et al., 2009), but analysis of 
terminals was beyond the scope of our study. 
Axonal mitochondria provide the energy required for motor protein-driven axonal 
transport and for ion exchange through Na/K-ATPases that are located on the 
intermodal axolemma (Mata et al., 1991; McGrail et al., 1991; Alberti et al., 2007; 
Young et al., 2008). In myelinated sciatic nerve fibers of both WT and Mecp2
+/-
 
mice, the mean axonal mitochondrial diameter was ~0.32 
m (Perge et al., 
2009). While tissue processing for electron microscopy will cause some degree of 
shrinkage that will vary according to the methodology, these size differences 
probably reflect mainly the fact that large caliber axons (as in the sciatic nerve) 
have a greater energy requirement per unit volume than small caliber axons, as in 
the optic nerve. 
in diameter, mitochondria therefore make up a constant proportion (~ 1.5%) of 
axoplasm volume, independent of axonal diameter. In other words, the number of 
mitochondria per axon should scale with axonal volume (and hence with axonal 
cross-sectional area, if we treat axons as regular cylinders). Although the density of 
mitochondria per unit cross-sectional area is higher in Mecp2
+/-
 mice than in WT 
mice, the increase is not in proportion given the ratio of diameters in the two 
genotypes (the axon diameter ratio is 1:1.27; the mitochondrial density should 
therefore scale with diameter squared i.e. 1.61:1; the observed ratio of 
mitochondrial densities is only 1.34:1). On the assumption that the mitochondria 
are the same length and have the same orientation relative the axonal long axis in 
the two genotypes, we therefore conclude that there may be fewer mitochondria 
per myelinated axon in Mecp2
+/-
 mice. This interesting observation needs to be 
followed up in more detailed studies of mitochondrial function in peripheral nerves 
in RTT models. 
Previous research on mice modeling RTT has focused on studying dysfunction 
within the central nervous system and revealed a variety of cellular and network 
features associated with MeCP2-deficiency, such as imbalance between cortical 
excitatory and inhibitory circuits (Dani et al., 2005), diminished synaptic plasticity 
(Asaka et al., 2006; Weng et al., 2011), as well as aberrant EEG (D'Cruz et al., 
2010), seizures (McLeod et al., 2013) and brainstem dysfunction leading to 
abnormal breathing patterns (Viemari et al., 2005). However, certain cardinal 
features of RTT in mouse models, such as hindlimb clasping (Shahbazian et al., 
2002; Guy et al., 2007; Gadalla et al., 2013) and gait abnormalities (Guy et al., 
2007; Gadalla et al., 2014), could potentially be a consequence of combined 
abnormalities of both central and peripheral nervous systems. Mouse models in 
which Mecp2 is selectively silenced either in the nervous system (Guy et al., 2001) 
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or in peripheral tissue (Luikenhuis et al., 2004; Ross et al., 2016), highlighted the 
pivotal role of the nervous system in the development of prominent RTT like 
phenotypes. However, these experiments do not discriminate the relative 
contribution of MeCP2 deficiency in peripheral nerves and the potential role of 
peripheral nerve dysfunction has generally been neglected, despite the early 
reported cases of peripheral nerve abnormalities in RTT patients, prior to the 
discovery of the genetic basis of the disorder (Haas and Love, 1988; Wakai et al., 
1990). The changes in sciatic nerve morphology of Mecp2
+/-
 mice in this study are 
similar to those reported in several animal models of other neurological conditions 
that are primarily considered to be brain disorders (Wade et al., 2008; Lopes et al., 
2016). Moreover, reduced axonal diameter in peripheral nerves has also been 
reported in IGF1-deficient mice, a phenotype that was reversed following IGF1 
administration (Gao et al., 1999). This could be relevant in RTT where IGF1 
tripeptide administration has been shown to rescue locomotion as well as structural 
abnormalities within the brain of Mecp2-null mice (Tropea et al., 2009).  
In conclusion, we report modest structural abnormalities in the peripheral nerves of 
Mecp2
+/-
 mice. The reduced axonal diameter mirrors morphological alterations 
seen in the brain, and could potentially contribute to certain RTT-like phenotypes. 
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Figure legends 
Figure 1. The diameter of nerve fibers and their axons is reduced in Mecp2
+/-
 
mice 
Figure 2. Analysis of g-ratio in sciatic nerve of Mecp2
+/-
 mice 
Figure 3. The density of unmyelinated axons in Mecp2
+/-
 mouse sciatic nerve is 
unaltered 
(A) Representative micrographs of Azur blue stained semi-thin transverse sections 
of the sciatic nerve, illustrating myelinated nerve fibers in WT (left) and Mecp2
+/-
 
mice (right). Graphs showing (B) mean fiber diameter, (C) fiber diameter 
frequency distribution, (D) mean axon diameter, (E) axon diameter frequency 
distribution, (F) plot showing mean density of myelinated axons within the sciatic 
nerve. Data are presented as mean ± S.E.M. (n=5 WT and 9 Mecp2
+/- 
mice). 
Unpaired Student’s t test was used to compare genotypes.* p <0.05, *** p ≤ 
0.0001.  
(A) Plot showing mean myelin thickness. (B) Plot of g-ratio versus axonal 
diameter. Note there is a tendency for a higher g-ratio (thinner than normal myelin) 
across all axon diameters in Mecp2
+/-
 compared to control samples. In B, each 
point represents a single fiber. Data in A are presented as mean ± S.E.M. (n=5 WT 
and 9 Mecp2
+/- mice). Unpaired Student’s t test was used to compare genotypes.** 
p <0.01. 
  
(A) Transmission electron micrographs of transverse section of the sciatic nerve 
showing myelinated (m) and unmyelinated axons (white arrows). Graph showing 
(B) mean diameter of unmyelinated axons and (C) density of unmyelinated fibers. 
Data are presented as mean ± SEM (n = 5 WT and 7 Mecp2
+/-  
mice). Unpaired t 
test was used to compare genotypes. Abbreviations: m: myelin; sc: Schwann cell 
nucleus; ax: axon. 
Figure 4. The number of mitochondria per myelinated axon cross-section is 
reduced in Mecp2
+/-
 mice 
 
(A) Transmission electron micrographs of transverse sections of the sciatic nerve 
showing mitochondria (arrows) in the axoplasm of myelinated (m) axons (ax). 
Graphs showing (B) the mean number of mitochondria per myelinated axon, (C) 
mean number of mitochondria per mm
2
 of the axoplasm of myelinated axons. Data 
are presented as mean ± SEM (n = 5 WT and 7 Mecp2
+/- 
mice). Unpaired t test was 
used to compare genotypes. * p < 0.05.  
Figure 5. Axonal mitochondria appear normal in Mecp2
+/- 
mice  
(A) Electron micrograph showing normal (black arrow) and abnormal (swollen and 
lacking cristae; white arrows). (B) Plot showing percentage of mitochondria in 
myelinated axons designated normal, abnormal or uncertain. (C) Plot showing 
mean cross-sectional diameter of axonal mitochondria.  Data are presented as mean 
± SEM (n = 5 WT and 7 Mecp2
+/- 
mice). There was no difference between 
genotypes in B (Chi-square test on raw counts) or C (unpaired unpaired t-test), all 
p > 0.05, ns = not significant.  
 Figure 6. Normal sciatic nerve conduction properties in Mecp2
+/-
 mice 
(A) Representative evoked compound action potentials in sciatic nerve from 10 
months old WT (n = 5) and Mecp2
+/-
 (n = 6) mice. (B) Plot showing no difference 
in conduction velocity between genotypes over increasing stimulus intensity (p > 
0.05, two-way ANOVA). (C) Plot of paired-pulse data showing the relative 
amplitude of the second pulse over varying inter-stimulus intervals. There was no 
change to refractory period between genotypes (p > 0.05, two-way ANOVA). 
  
Research Highlights 
 
 A mouse model of Rett syndrome reveals a reduced diameter of peripheral 
myelinated nerve fibers 
 Mitochondrial densities per unit area of axoplasm are significantly altered in 
Mecp2
+/-
 mice 
 There is no detectable change in mitochondrial integrity or nerve conduction 
properties between Mecp2
+/-
 and wild-type mice 
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